Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Sep 01, 2016
- Source ID
- 10.1016/j.bbmt.2016.06.012
Entities
People
- Ami S. Bhatt
- Ayman Saad
- Baldeep Wirk
- Biju George
- Bipin N Savani
- Caroline Lindemans
- Celalettin Ustun
- Christopher Dandoy
- Daniel J Weisdorf
- David A. Margolis
- David I. Marks
- Edmund K Waller
- George Chen
- Harry C. Schouten
- Hillard M Lazarus
- Hisham Abdel-azim
- Ibrahim Ahmed
- Jan Storek
- Jeffrey Auletta
- Jo-Anne H. Young
- John R Wingard
- Joseph Antin
- Joseph Rosenthal
- Karen Ballen
- Kirsten M. Williams
- Krishna V. Komanduri
- Kwang Woo Ahn
- Mahmoud Aljurf
- Marcie L. Riches
- Margaret L MacMillan
- Mary J. Laughlin
- Maxim Norkin
- Michael Boeckh
- Michael R Verneris
- Min Chen
- Paul Szabolcs
- Tom Wolfs
Organizations
- Alexion Pharmaceuticals
- Amgen
- Bristol-Myers Squibb
- Celgene
- Chiron Corporation
- Elevance Health, Inc.
- Fred Hutchinson Cancer Center
- Genzyme
- Gilead Sciences
- Health Research
- Health Resources and Services Administration
- HistoGenetics (United States)
- Incyte
- Jazz Pharmaceuticals
- Leukemia & Lymphoma Society
- Medical College of Wisconsin
- Merck & Co.
- Miltenyi Biotec
- National Cancer Institute
- National Heart, Lung, and Blood Institute
- National Institute of Allergy and Infectious Diseases
- National Marrow Donor Program
- Office of Naval Research
- Onyx Pharmaceuticals
- Otsuka (United States)
- Otsuka Pharmaceutical
- Pharmacyclics
- Roche (United States)
- Roswell Park Comprehensive Cancer Center
- Sanofi-Aventis
- Seagen
- Sigma-Tau Pharmaceuticals (United States)
- Spectrum Pharmaceuticals
- St. Baldrick's Foundation
- Swedish Orphan Biovitrum
- Takeda Oncology
- University of Minnesota